Similar articles

• Modification of the vascular lesions of rejection in cadaveric renal allografts by dipyridamole and anticoagulants.

  Kincaid-Smith P. Kincaid-Smith P. Lancet. 1969 Nov 1;2(7627):920-2. doi: 10.1016/s0140-6736(69)90587-x. Lancet. 1969. PMID: 4186594 No abstract available.
• The pathogenesis of the vascular and glomerular lesions of rejection in renal allografts and their modification by antithromtotic and anticoagulant drugs.

  Kincaid-Smith P. Kincaid-Smith P. Australas Ann Med. 1970 Aug;19(3):201-14. doi: 10.1111/imj.1970.19.3.201. Australas Ann Med. 1970. PMID: 4394286 No abstract available.
• The treatment of rejection. A trial of acetylsalicylic acid, dipyridamole, and heparin.

  George CR, Slichter SJ, Quadracci LJ, Kenny GM, Dennis MB Jr, Striker GE, Harker LA. George CR, et al. Transplantation. 1975 Sep;20(3):237-40. doi: 10.1097/00007890-197509000-00008. Transplantation. 1975. PMID: 1099729
• [Prevention of thrombosis with coumarin, low doses of heparin, dextran and inhibitors of platelet function].

  Loeliger EA. Loeliger EA. Ned Tijdschr Geneeskd. 1977 Oct 29;121(44):1748-54. Ned Tijdschr Geneeskd. 1977. PMID: 335258 Review. Dutch. No abstract available.
• [Prevention of postoperative thrombo-embolic complications. The principal methods, other than low-dose heparin].

  Kher A, Toulemonde F. Kher A, et al. Ann Chir. 1977 Nov;31(11):991-7. Ann Chir. 1977. PMID: 345934 Review. French. No abstract available.